Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04483544
Title Pembrolizumab and Olaparib in Cervical Cancer Patients
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Baptist Health South Florida
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.